Literature DB >> 26631828

The current landscape of the mesenchymal stromal cell secretome: A new paradigm for cell-free regeneration.

Vijay Bhaskar Reddy Konala1, Murali Krishna Mamidi2, Ramesh Bhonde2, Anjan Kumar Das3, Radhika Pochampally4, Rajarshi Pal5.   

Abstract

The unique properties of mesenchymal stromal/stem cells (MSCs) to self-renew and their multipotentiality have rendered them attractive to researchers and clinicians. In addition to the differentiation potential, the broad repertoire of secreted trophic factors (cytokines) exhibiting diverse functions such as immunomodulation, anti-inflammatory activity, angiogenesis and anti-apoptotic, commonly referred to as the MSC secretome, has gained immense attention in the past few years. There is enough evidence to show that the one important pathway by which MSCs participate in tissue repair and regeneration is through its secretome. Concurrently, a large body of MSC research has focused on characterization of the MSC secretome; this includes both soluble factors and factors released in extracellular vesicles, for example, exosomes and microvesicles. This review provides an overview of our current understanding of the MSC secretome with respect to their potential clinical applications.
Copyright © 2015 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cell therapy; exosomes; mesenchymal stromal cells; regeneration; secretome

Mesh:

Year:  2015        PMID: 26631828      PMCID: PMC4924535          DOI: 10.1016/j.jcyt.2015.10.008

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  81 in total

1.  Cancer cells use exosomes as tools to manipulate immunity and the microenvironment.

Authors:  Aled Clayton
Journal:  Oncoimmunology       Date:  2012-01-01       Impact factor: 8.110

Review 2.  Dendritic cell-derived exosomes for cancer immunotherapy: what's next?

Authors:  Sophie Viaud; Clotilde Théry; Stéphanie Ploix; Thomas Tursz; Valérie Lapierre; Olivier Lantz; Laurence Zitvogel; Nathalie Chaput
Journal:  Cancer Res       Date:  2010-02-09       Impact factor: 12.701

3.  Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury.

Authors:  Ruenn Chai Lai; Fatih Arslan; May May Lee; Newman Siu Kwan Sze; Andre Choo; Tian Sheng Chen; Manuel Salto-Tellez; Leo Timmers; Chuen Neng Lee; Reida Menshawe El Oakley; Gerard Pasterkamp; Dominique P V de Kleijn; Sai Kiang Lim
Journal:  Stem Cell Res       Date:  2010-01-04       Impact factor: 2.020

Review 4.  Mesenchymal Stem Cell-derived Extracellular Vesicles: Toward Cell-free Therapeutic Applications.

Authors:  Sweta Rani; Aideen E Ryan; Matthew D Griffin; Thomas Ritter
Journal:  Mol Ther       Date:  2015-03-19       Impact factor: 11.454

5.  Results of a pilot study involving the use of an antisense oligodeoxynucleotide directed against the insulin-like growth factor type I receptor in malignant astrocytomas.

Authors:  D W Andrews; M Resnicoff; A E Flanders; L Kenyon; M Curtis; G Merli; R Baserga; G Iliakis; R D Aiken
Journal:  J Clin Oncol       Date:  2001-04-15       Impact factor: 44.544

6.  Monocyte chemotactic protein-3 is a myocardial mesenchymal stem cell homing factor.

Authors:  Soren Schenk; Niladri Mal; Amanda Finan; Ming Zhang; Matt Kiedrowski; Zoran Popovic; Patrick M McCarthy; Marc S Penn
Journal:  Stem Cells       Date:  2006-10-19       Impact factor: 6.277

7.  Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease.

Authors:  Neelam K Venkataramana; Satish K V Kumar; Sudheer Balaraju; Radhika Chemmangattu Radhakrishnan; Abhilash Bansal; Ashish Dixit; Deepthi K Rao; Madhulita Das; Majahar Jan; Pawan Kumar Gupta; Satish M Totey
Journal:  Transl Res       Date:  2009-08-06       Impact factor: 7.012

8.  Mesenchymal stem cells secrete immunologically active exosomes.

Authors:  Bin Zhang; Yijun Yin; Ruenn Chai Lai; Soon Sim Tan; Andre Boon Hwa Choo; Sai Kiang Lim
Journal:  Stem Cells Dev       Date:  2014-02-10       Impact factor: 3.272

9.  Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo.

Authors:  Alain J Poncelet; Jonathan Vercruysse; Alain Saliez; Pierre Gianello
Journal:  Transplantation       Date:  2007-03-27       Impact factor: 4.939

10.  Exosomes derived from mesenchymal stem cells suppress angiogenesis by down-regulating VEGF expression in breast cancer cells.

Authors:  Jong-Kuen Lee; Sae-Ra Park; Bong-Kwang Jung; Yoon-Kyung Jeon; Yeong-Shin Lee; Min-Kyoung Kim; Yong-Goo Kim; Ji-Young Jang; Chul-Woo Kim
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

View more
  124 in total

Review 1.  Mesenchymal stem/stromal cell-derived exosomes in regenerative medicine and cancer; overview of development, challenges, and opportunities.

Authors:  Ali Hassanzadeh; Heshu Sulaiman Rahman; Alexander Markov; Judi Januadi Endjun; Angelina Olegovna Zekiy; Max Stanley Chartrand; Nasrin Beheshtkhoo; Mohammad Amin Jadidi Kouhbanani; Faroogh Marofi; Marzieh Nikoo; Mostafa Jarahian
Journal:  Stem Cell Res Ther       Date:  2021-05-21       Impact factor: 6.832

Review 2.  Emergence of the Stem Cell Secretome in Regenerative Engineering.

Authors:  Leila Daneshmandi; Shiv Shah; Tahereh Jafari; Maumita Bhattacharjee; Deandra Momah; Nikoo Saveh-Shemshaki; Kevin W-H Lo; Cato T Laurencin
Journal:  Trends Biotechnol       Date:  2020-07-01       Impact factor: 19.536

3.  Prostaglandin EP2 Receptors Mediate Mesenchymal Stromal Cell-Neuroprotective Effects on Dopaminergic Neurons.

Authors:  Juan Andrés Parga; María García-Garrote; Salvador Martínez; Ángel Raya; José Luis Labandeira-García; Jannette Rodríguez-Pallares
Journal:  Mol Neurobiol       Date:  2017-07-17       Impact factor: 5.590

4.  Mesenchymal Stem Cell-Derived Exosomes: New Opportunity in Cell-Free Therapy.

Authors:  Davod Pashoutan Sarvar; Karim Shamsasenjan; Parvin Akbarzadehlaleh
Journal:  Adv Pharm Bull       Date:  2016-09-25

5.  Mesenchymal Stem/Stromal Cells in Regenerative Medicine: Can Preconditioning Strategies Improve Therapeutic Efficacy?

Authors:  Richard Schäfer; Gabriele Spohn; Patrick C Baer
Journal:  Transfus Med Hemother       Date:  2016-07-20       Impact factor: 3.747

6.  Optimization of lentiviral transduction parameters and its application for CRISPR-based secretome modification of human endometrial mesenchymal stem cells.

Authors:  Pavel Deryabin; Anastasiia Griukova; Alla Shatrova; Alexey Petukhov; Nikolay Nikolsky; Aleksandra Borodkina
Journal:  Cell Cycle       Date:  2019-03-28       Impact factor: 4.534

7.  Exosomal MicroRNAs Derived From Umbilical Mesenchymal Stem Cells Inhibit Hepatitis C Virus Infection.

Authors:  Xijing Qian; Chen Xu; Shuo Fang; Ping Zhao; Yue Wang; Houqi Liu; Wen Yuan; Zhongtian Qi
Journal:  Stem Cells Transl Med       Date:  2016-08-05       Impact factor: 6.940

8.  Effects of mesenchymal stromal cells on motor function and collagen in the skeletal muscles of rats with type I diabetes.

Authors:  Genoveva L F Luna; Thiago L Russo; Maria A Sabadine; Yisel C Estrada-Bonilla; Ana L M Andrade; Patricia Brassolatti; Fernanda F Anibal; Ângela M O Leal
Journal:  Int J Exp Pathol       Date:  2020-02-06       Impact factor: 1.925

Review 9.  A New Chapter for Mesenchymal Stem Cells: Decellularized Extracellular Matrices.

Authors:  Yagiz Anasiz; Riza Koksal Ozgul; Duygu Uckan-Cetinkaya
Journal:  Stem Cell Rev Rep       Date:  2017-10       Impact factor: 5.739

10.  Fortune Favors the Prepared: Safety and Efficacy of Allogeneic Hypoxia Preconditioned Mesenchymal Stromal Cells in Primates.

Authors:  Gabriela M Kuster; Ronglih Liao
Journal:  Circ Res       Date:  2016-03-18       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.